| GlaxoSmithKline EC Grants Conditional Marketing OK For Votrient - Wall Street Journal |
|
|
Wall Street Journal... for the first-line treatment of advanced Renal Cell Carcinoma and for patients who have received prior cytokine therapy for advanced disease. ... read more |